1. Home
  2. FUL vs DYN Comparison

FUL vs DYN Comparison

Compare FUL & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo H. B. Fuller Company

FUL

H. B. Fuller Company

HOLD

Current Price

$60.67

Market Cap

3.1B

Sector

Industrials

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$18.71

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUL
DYN
Founded
1887
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.0B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
FUL
DYN
Price
$60.67
$18.71
Analyst Decision
Buy
Strong Buy
Analyst Count
5
14
Target Price
$68.40
$37.00
AVG Volume (30 Days)
708.2K
2.3M
Earning Date
03-25-2026
05-07-2026
Dividend Yield
1.55%
N/A
EPS Growth
19.57
N/A
EPS
0.38
N/A
Revenue
$2,897,000,000.00
N/A
Revenue This Year
$4.96
N/A
Revenue Next Year
$4.00
N/A
P/E Ratio
$159.45
N/A
Revenue Growth
N/A
N/A
52 Week Low
$47.56
$7.01
52 Week High
$68.63
$25.00

Technical Indicators

Market Signals
Indicator
FUL
DYN
Relative Strength Index (RSI) 55.30 57.54
Support Level $57.24 $18.32
Resistance Level $60.57 $19.65
Average True Range (ATR) 2.26 1.08
MACD 1.19 0.02
Stochastic Oscillator 79.78 81.40

Price Performance

Historical Comparison
FUL
DYN

About FUL H. B. Fuller Company

H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. It generates the maximum revenue from hygiene, health, and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven, and hygiene (disposable diapers, feminine care, and medical garments) and health and beauty. The company generates around half of its revenue in the United States.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: